Back to the full story6 sources · AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb◆ All Sources

AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb

4 regions · 6 outlets · 6 reports — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.

Other

2 articles · 2 outlets

QuartzAug 3, 12:30 PM

The Straits TimesAug 2, 8:04 PM

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion mega deal: Report

US

2 articles · 2 outlets

MarketWatchAug 3, 12:13 PM

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd

CNBCAug 3, 11:35 AM

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed

UK

1 article · 1 outlet

The Guardian USAug 3, 10:22 AM

AstraZeneca holds talks with US cancer drug developer in $400bn merger

International

1 article · 1 outlet

ReutersAug 3, 10:05 AM

AstraZeneca investors balk at $400 billion Bristol Myers tie-up reports

Discover AIPROPX

LiveLive WireEvery report as it lands PopularTrendingMost-covered events now BrowseTop StoriesThe corroborated record FindSearchAny story, topic, or outlet